Bacteria and Diseases of Unknown Cause: Hemolytic-Uremic Syndrome

Journal of Infectious Diseases

Volumn 189, Issue 3, 2004, Pages 552-563

  Blaser, Martin J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ANIMAL HUSBANDRY; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; DISEASE ASSOCIATION; EPIDEMIC; ESCHERICHIA COLI; FOOD SAFETY; GUILLAIN BARRE SYNDROME; HEMOLYTIC UREMIC SYNDROME; HUMAN; MANURE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; CANADA; ECOLOGY; ESCHERICHIA COLI O157; FOOD MICROBIOLOGY; HEMOLYTIC-UREMIC SYNDROME; HUMANS; UNITED STATES; WORLD HEALTH;

EID: 1142273117     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/381129     Document Type: Review

References (30)

1. Gasser C, Gautier E, Steck A, Siebenmann RE, Oechslin R. Hamolytisch-uramische syndrome: bilaterale nierenrindennekrosen bei akuten erworbenen hamolytischen anamien. Schweiz Med Wochenschr 1955; 85:905-9.
2. Fong JSC, de Chadarevian J-P, Kaplan BS. Hemolytic-uremic syndrome: current concepts and management. Pediatr Clin North Am 1982; 29:835-56.
3. Kaplan BS, Drummond KN. The hemolytic-uremic syndrome is a syndrome. N Engl J Med 1978; 298:964-6.
4. McLean MM, Jones CH, Sutherland DA. Haemolytic-uraemic syndrome: a report of an outbreak. Arch Dis Child 1966; 41:76-81.
5. Steele BT, Murphy N, Arbus GS, Rance CP. An outbreak of hemolytic uremic syndrome associated with ingestion of fresh apple juice. J Pediatr 1982; 101:963-5.
6. Riley LW, Remis RS, Helgerson SD, et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 1983; 308:681-5.
7. Konowalchuk J, Speirs JI, Stavric S. Vero response to a cytotoxin of Escherichia coli. Infect Immun 1977; 18:775-9.
8. Skirrow MB. Campylobacter enteritis, a "new" disease. Br Med J 1977; 2:9-11.
9. Karmali MA, Fleming PC. Campylobacter enteritis in children. J Pediatr 1979; 94:527-33.
10. Karmali MA, Steele BT, Petric M, Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 1983; 1:619-20.
11. Johnson WM, Lior H, Bezanson GS. Cytotoxic Escherichia coli O157:H7 associated with haemorrhagic colitis in Canada [letter]. Lancet 1983; 1:76.
12. O'Brien AD, Lively TA, Chen ME, Rothman SW, Formal SB. Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (Shiga) like cytotoxin [letter]. Lancet 1983; 1:702.
13. Karmali MA, Petric M, Lim C, Fleming PC, Steele BT. Escherichia coli cytotoxin, haemolytic-uraemic syndrome, and haemorrhagic colitis. Lancet 1983; 2:1299-300.
14. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 1985; 151: 775-82.
15. Griffin PM, Mead PS, Sivapalasingam S. Escherichia coli O157:H7 and other enterohemorrhagic E. coli. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg H, Guerrant RL, eds. Infections of the gastrointestinal track. 2nd ed. Philadelphia: Lippincott, Williams & Wilkins, 2002; 627-42.
16. Kaper JB, O'Brien AD. Escherichia coli O157:H7 and other shiga toxin-producing E. coli strains. Washington, DC: American Society for Microbiology, 1998.
17. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998; 11:142-201.
18. Lathem WW, Bergsbaker T, Witowski SE, Perna NT, Welch RA. Acquisition of stcE, a C1 esterase inhibitor-specific metalloprotease, during the evolution of Escherichia coli O157:H7. J Infect Dis 2003; 187: 1907-14.
19. Lingwood CA, Law H, Richardson S, et al. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem 1987; 262:8834-9.
20. Reisbig R, Olsnes S, Eiklid K. The cytotoxic activity of Shigella toxin: evidence of catalytic inactivation of the 60S ribosomal subunit. J Biol Chem 1981; 256:8739-44.
21. Richardson SE, Rotman TA, Jay V, et al. Experimental verocytotoxemia in rabbits. Infect Immun 1992; 60:4154-67.
22. Rees JH, Soudain SE, Gregory NA, Hughes RAN. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995; 333:1374-9.
23. Peek RM, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002; 2:28-37.
24. Blaser MJ. Bacteria and diseases of unknown cause. Ann Intern Med 1994; 121:144-5.
25. Sperandio V, Torres AG, Jarvis B, Nataro JP, Kaper JB. Bacteria-host communication: the language of hormones. PNAS 2003; 100:8951-6.
26. Perna NT, Plunkett G 3rd, Burland V, et al. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 2001; 409:529-33.
27. Hayashi T, Makino K, Ohnishi M, et al. Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Res 2001; 8:11-22.
28. Cody SH, Glynn MK, Farrar JA, et al. An outbreak of Escherichia coli O157:H7 infection from unpasteurized commercial apple juice. Ann Intern Med 1999; 130:202-9.
29. Diez-Gonzalez F, Callaway TR, Kizoulis MG, Russell JB. Grain feeding and the dissemination of acid-resistant Escherichia coli from cattle. Science 1998; 281:1666-8.
30. US Food and Drug Administration. Hazard analysis and critical control point (HACCP); procedures for the safe and sanitary processing and importing of juice; food labeling; warning notice statements; labeling of juice products; proposed rules. Federal Register, 1998; 63:20449-86.